skip to content
Systematic Reviews of Treatments for Multiple Sclerosis
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for multiple sclerosis.
Reviewed October 2010
30 Resources Found
Results 1 to 20 displayed. 1 2
| Title: | Rituximab for relapsing-remitting multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Recent studies showed that a class of white blood cells (B lymphocytes) can be involved in the pathology of MS. This feature has led to a renewed interest in therapies directed to control B-cells activities. Rituximab belongs to the class of monoclonal... |
| Date: | Aug 2011 |
| Title: | Statins for multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | MS is an inflammatory demyelinating disease of the human central nervous system and it is thought to be related to abnormal working of the immune system. Preliminary studies have shown that statins, cholesterol lowering agents, have potential immunolog... |
| Date: | Aug 2011 |
| Title: | Hyperbaric oxygen therapy for multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middle-aged adults. Repeated damage to parts of the nerves leads to progressive weakness and disability. Hyperbaric oxygen therapy (HBOT) involves people breathin... |
| Date: | May 2011 |
| Title: | Multidisciplinary rehabilitation for adults with multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Multiple sclerosis is a chronic neurological condition, which can cause multiple disabilities and limit participation in young adults. This review looked for evidence of MD rehabilitation in adults with multiple sclerosis. The authors concluded there wa... |
| Date: | Apr 2011 |
| Title: | Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Major as well as minor disabilities, such as physical, psychosocial, environmental and memory/attention impairment, significantly affect the entering or the returning to work of persons with MS. The objective of this review was to assess the efficacy an... |
| Date: | Mar 2011 |
| Title: | Neuropsychological rehabilitation for multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Recently, new studies have challenged the historical view of MS merely as a demyelinating disease and made it evident that also widespread lesions of the nerves (axonal damage) and grey matter changes are central features of MS. This has emphasized the... |
| Date: | Mar 2011 |
| Title: | Pharmacologic treatment of depression in multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Many patients with multiple sclerosis (MS) suffer from depression. In this review we summarized studies of antidepressant drug treatments in patients with MS. We found two studies that met the inclusion criteria of methodological quality, comprising of ... |
| Date: | Dec 2010 |
| Title: | Vitamin D for the management of multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Multiple sclerosis is an illness in which the myelin sheaths around the nerves of the brain and spinal cord are damaged, affecting the ability of nerve cells to communicate with each other. A wide range of clinical presentations and neurological symptom... |
| Date: | Jun 2010 |
| Title: | Daclizumab for relapsing remitting multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Monoclonal antibodies such as daclizumab could be a possible alternative to interferon beta treatment in MS. This review attempted to evaluate if daclizumab, alone or combined to other treatments, is generally effective and safe as a therapy for relapsi... |
| Date: | Mar 2010 |
| Title: | Glatiramer acetate for multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | This is an updated Cochrane review of the previous version published (Cochrane Database of Systematic Reviews 2004 , Issue 1 . Art. No.: CD004678. DOI: 10.1002/14651858.CD004678) Treatment with glatiramer acetate (Copaxone ®) of patients with Relapsin... |
| Date: | Sep 2009 |
| Title: | Interferon Beta for Primary Progressive Multiple Sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | This is an updated Cochrane review of the previous version published (Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD006643. DOI: 10.1002/14651858.CD006643.pub2). Treatments of patients with Primary Progressive Multiple Sclerosis ( P... |
| Date: | Aug 2009 |
| Title: | Intravenous immunoglobulins for multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Multiple sclerosis (MS) is a chronic immune-mediated disease of the nervous system that affects young and middle-aged adults and can lead to permanent disability. Immunoglobulins have several effects on the immune system, and help fight infections. The ... |
| Date: | Jan 2009 |
| Title: | Oral versus intravenous steroids for treatment of relapses in multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Relapsing-remitting MS is characterised by periods of disability due to inflammation in the central nervous system. These episodes are called relapses. All research has shown that a speed up recovery is obtained by corticosteroids, given most often in i... |
| Date: | Aug 2008 |
| Title: | Treatment of seizures in multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Epileptic seizures occur in a relatively small number of patients with multiple sclerosis, but can have serious consequences. Because the cause of epileptic seizures in patients in MS may be different from that in other forms of epilepsy, it is uncertai... |
| Date: | Feb 2008 |
| Title: | Anticholinergics for urinary symptoms in multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Urinary symptoms are very common in people with multiple sclerosis, reflecting the high prevalence of damage to the spinal cord from MS. Symptoms may change with time due to either progression or MS relapses. Common symptoms include frequency, urgency a... |
| Date: | Jan 2008 |
| Title: | Methotrexate for multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Multiple sclerosis (MS) is an immune disease of the nervous system. Drugs that interfere with the immune system, such as methotrexate could benefit people with the disease. To date research suggest that there may be small improvements from treatment wit... |
| Date: | Oct 2007 |
| Title: | Corticosteroids for the long-term treatment in multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Multiple sclerosis is an inflammatory disease affecting the brain and spinal cord. It results in episodes of neurological deficit which recover (relapses) as well as accumulation of sustained disability with the passage of time. Corticosteroids are pote... |
| Date: | Aug 2007 |
| Title: | Azathioprine for multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | AZA is a possible alternative to interferon beta for treating MS. As concerns have been raised about its safety, mainly due to possible increased risk of cancer, the authors of this review tried to assess the balance between benefits and harms of AZA tr... |
| Date: | May 2007 |
| Title: | Interferon in relapsing-remitting multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middle-aged adults. Repeated damage to the myelin sheaths and other parts of the nerves can lead to serious disability. MS may be related to the immune system. In... |
| Date: | Apr 2007 |
| Title: | Amantadine for fatigue in multiple sclerosis |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Multiple sclerosis (MS) is a chronic disease affecting young and middle-aged adults. One of the most common and disabling symptoms of MS is fatigue. Different approaches have been used to try and improve this, including energy conservation, specialised ... |
| Date: | Nov 2006 |
Results 1 to 20 displayed. 1 2
